000 01182 a2200313 4500
005 20250514200632.0
264 0 _c20040916
008 200409s 0 0 eng d
022 _a1170-7690
024 7 _a10.2165/00019053-200018040-00006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMavissakalian, M R
245 0 0 _aCost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder.
_h[electronic resource]
260 _bPharmacoEconomics
_cOct 2000
300 _a383-91 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aClinical Trials as Topic
650 0 4 _aCost-Benefit Analysis
650 0 4 _aHealth Care Costs
650 0 4 _aHumans
650 0 4 _aImipramine
_xadministration & dosage
650 0 4 _aPanic Disorder
_xdrug therapy
650 0 4 _aQuality-Adjusted Life Years
700 1 _aSchmier, J K
700 1 _aFlynn, J A
700 1 _aRevicki, D A
773 0 _tPharmacoEconomics
_gvol. 18
_gno. 4
_gp. 383-91
856 4 0 _uhttps://doi.org/10.2165/00019053-200018040-00006
_zAvailable from publisher's website
999 _c15040684
_d15040684